Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Other Non-Current Liabilities (2023 - 2026)

Camp4 Therapeutics' Other Non-Current Liabilities history spans 3 years, with the latest figure at $44.8 million for Q4 2025.

  • On a quarterly basis, Other Non-Current Liabilities changed N/A to $44.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $44.8 million, a N/A change, with the full-year FY2025 number at $44.8 million, changed N/A from a year prior.
  • Other Non-Current Liabilities hit $44.8 million in Q4 2025 for Camp4 Therapeutics, up from $16.7 million in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for CAMP hit a ceiling of $44.8 million in Q4 2025 and a floor of $2000.0 in Q4 2023.
  • Historically, Other Non-Current Liabilities has averaged $10.2 million across 3 years, with a median of $2000.0 in 2023.
  • The widest YoY moves for Other Non-Current Liabilities: up 836500.0% in 2025, down 836500.0% in 2025.
  • Tracing CAMP's Other Non-Current Liabilities over 3 years: stood at $2000.0 in 2023, then changed by 0.0% to $2000.0 in 2024, then skyrocketed by 2237900.0% to $44.8 million in 2025.
  • Business Quant data shows Other Non-Current Liabilities for CAMP at $44.8 million in Q4 2025, $16.7 million in Q3 2025, and $2000.0 in Q2 2025.